Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo

scientific article published in April 1997

Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID9111517

P2093author name stringRao JS
Johnston P
Rosen E
Goldberg ID
Laterra J
Lamszus K
Nam M
P433issue4
P304page(s)565-577
P577publication date1997-04-01
P1433published inLaboratory InvestigationQ6467260
P1476titleScatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo
P478volume76

Reverse relations

cites work (P2860)
Q33710008A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer
Q51031755A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).
Q34785157Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.
Q89964020Adipose-Derived Molecules-Untouched Horizons in Alzheimer's Disease Biology
Q30428363An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth
Q37329927An update in the use of antibodies to treat glioblastoma multiforme
Q33756853EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.
Q34127138Experimental approaches for the treatment of malignant gliomas
Q55474355Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
Q34178906Genes that regulate metastasis and angiogenesis
Q41730938HGF/SF in Angiogenesis
Q39214964HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and Therapeutics
Q26781273Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge
Q30437740Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy
Q92912403MET in glioma: signaling pathways and targeted therapies
Q27021470Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma
Q30434616MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes
Q37879581Microvascular Modifications in Diabetic Retinopathy
Q34480160Molecular biology of nervous system tumors
Q47296083Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma
Q24629814Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
Q38812830Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion
Q36021591Perspectives of cellular and molecular neurosurgery
Q41966511Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF)
Q55262612Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.
Q24683896Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
Q55474924Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.
Q64956698The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.
Q48635543The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival
Q38008966The molecular profile of microglia under the influence of glioma
Q41062315Tumor-Associated Macrophages in Glioma: Friend or Foe?
Q28362076c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma

Search more.